Stopped: The study was unable to meet enrollment goals
The purpose of this study is to see what effects sacral neuromodulation has on bladder function and quality of life in patients with acute spinal cord injury. Within 12-weeks of injury, participants will either receive an implanted nerve stimulator (like a pace-maker for the bladder) or standard care for neurogenic bladder. Patients will be assigned to one of these groups at random and followed for one year. The hypothesis is that early stimulation of the nerves will help prevent the development of neurogenic bladder.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Maximum Cystometric Capacity
Timeframe: 12 months
Quality of Life Differences Measured by Mean SCI-QoL
Timeframe: 12 months
Number of Urinary Tract Infections Requiring Antibiotics
Timeframe: from enrollment through the end of follow-up at 12 months